April 19, 2024

The number of individuals recovering from the coronavirus disease-2019 (Covid-19) is one of the positive developments that keep the medical experts’ optimism that the battle against the infection will be won anytime soon.

While the Cordillera recorded its first Covid-19-related death and with the new positive cases being added to the region’s tally, health professionals find comfort in the number of individuals recovering from the infection.

On April 7, the Baguio General Hospital and Medical Center sent home two more patients who succeeded in their battle against the Covid-19.

The 31-year-old male from Metro Manila and a 49-year-old Baguio resident, who frequently travels to Manila, are the sixth and seventh patients who were discharged at the health facility after their test results showed they are free of the virus that causes the Covid-19.

BGHMC Chief Ricardo Ruñez said he is hopeful more patients will recover in the coming days.  

“We hope that everybody recovers (from the disease),” Ruñez said during an online briefing.

The seven patients who recovered are among the 14 Covid-19 positive patients listed in Baguio.

Based on the tally of the City Health Services Office as of 5 p.m. of April 7, six patients are still admitted in hospitals.

The first death in the region is a resident of the city. Based on the CHSO record, the 55-year-old female who died on March 19 had an existing lung infection before she developed symptoms of the Covid-19.

Meanwhile, records of the Department of Health-Cordillera showed that as of April 6, Abra and Benguet have one additional case each bringing to three the total number of cases in the two provinces.

Both recorded one recovery each.

The four provinces – Apayao, Ifugao, Kalinga, and Mountain Province – remain free from the disease.

Health officials in these provinces attributed the zero Covid-19 cases in their areas to the strict implementation of checkpoints leading to the localities, among the other measures implemented by the local government units through their respective inter-agency task force on the management of emerging diseases. – Jane B. Cadalig